108 related articles for article (PubMed ID: 21728116)
1. Chapter 3-3. Appendix: Drug-resistant anaerobes.
;
J Infect Chemother; 2011 Jul; 17 Suppl 1():162-4. PubMed ID: 21728116
[No Abstract] [Full Text] [Related]
2. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Liu CY; Huang YT; Liao CH; Yen LC; Lin HY; Hsueh PR
Antimicrob Agents Chemother; 2008 Sep; 52(9):3161-8. PubMed ID: 18625771
[TBL] [Abstract][Full Text] [Related]
3. Activity of linezolid against anaerobic bacteria.
Behra-Miellet J; Calvet L; Dubreuil L
Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Snydman DR; Jacobus NV; McDermott LA
Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2006 Oct; 50(10):3507-13. PubMed ID: 16940056
[TBL] [Abstract][Full Text] [Related]
6. Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin.
Ednie L; Shapiro S; Appelbaum PC
Diagn Microbiol Infect Dis; 2007 May; 58(1):133-6. PubMed ID: 17240107
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes].
Dubreuil L; Houcke I; Singer E
Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
Behra-Miellet J; Dubreuil L; Calvet L
Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study].
Grollier G; Mory F; Quentin C; Girard-Pipau F; Tigaud S; Sedallian A; Dubreuil L
Pathol Biol (Paris); 1994 May; 42(5):498-504. PubMed ID: 7824321
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
Antimicrob Agents Chemother; 2010 Apr; 54(4):1627-32. PubMed ID: 20100877
[TBL] [Abstract][Full Text] [Related]
11. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
Kierzkowska M; Majewska A; Sawicka-Grzelak A; Młynarczyk A; Ładomirska-Pestkowska K; Młynarczyk G
Med Dosw Mikrobiol; 2012; 64(1):29-34. PubMed ID: 22808727
[TBL] [Abstract][Full Text] [Related]
12. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
[TBL] [Abstract][Full Text] [Related]
13. German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study.
Seifert H; Dalhoff A;
J Antimicrob Chemother; 2010 Nov; 65(11):2405-10. PubMed ID: 20851813
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
[TBL] [Abstract][Full Text] [Related]
16. [Changes in sensitivity of clinical strains of bacteria to dioxidine from 1984 to 1988].
Bol'shakov LV
Antibiot Khimioter; 1990 Sep; 35(9):17-9. PubMed ID: 2275583
[TBL] [Abstract][Full Text] [Related]
17. Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Haas W; Pillar CM; Zurenko GE; Lee JC; Brunner LS; Morris TW
Antimicrob Agents Chemother; 2009 Aug; 53(8):3552-60. PubMed ID: 19506065
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
Odou MF; Muller C; Calvet L; Dubreuil L
J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
Montiel F; Kaltwasser G; Pinto ME; Lam M
Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
[TBL] [Abstract][Full Text] [Related]
20. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
